Product/Composition:- | Tenofovir AF + Emtricitabine |
---|---|
Strength:- | Tenofovir AF 25 mg + Emtricitabine 200 mg |
Form:- | Tablet |
Reference Brands:- | Descovy(EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Tenofovir Alafenamide (TAF) + Emtricitabine, sold as Descovy, is a once-daily HIV-1 treatment and PrEP option. It offers strong viral suppression with improved kidney and bone safety compared to TDF-based regimens. FDA and EMA approved.
Tenofovir Alafenamide (TAF) + Emtricitabine is a modern, once-daily antiretroviral combination used for the treatment and prevention of HIV-1 infection. Marketed under the brand name Descovy, this formulation offers a safer alternative to TDF-based regimens, with improved renal and bone safety. TAF is a prodrug of tenofovir, delivering effective viral suppression at a lower dose. Combined with Emtricitabine, an NRTI, it forms the backbone of several HIV therapies like Biktarvy, Genvoya, and Odefsey. Approved by the FDA and EMA, TAF + Emtricitabine is also used in PrEP to reduce the risk of HIV transmission in high-risk populations.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications